Common Stock, Shares Authorized of Transcode Therapeutics, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Transcode Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and change rate from Q4 2020 to Q3 2025.
  • Transcode Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending 30 Sep 2025 was 290M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Transcode Therapeutics, Inc. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 290M 0 0% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 290M 0 0% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 290M 0 0% 31 Mar 2025 10-Q 14 May 2025
Q4 2024 290M 0 0% 31 Dec 2024 10-Q 14 Nov 2025
Q3 2024 290M 0 0% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 290M 0 0% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 290M 0 0% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 290M 0 0% 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 290M 0 0% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 290M 0 0% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 290M 0 0% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 290M 0 0% 31 Dec 2022 10-K 01 Apr 2024
Q3 2022 290M 0 0% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 290M 0 0% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 290M 31 Mar 2022 10-Q 16 May 2022
Q4 2021 290M +270M +1350% 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 290M 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 290M 30 Jun 2021 10-Q 23 Aug 2021
Q4 2020 20M 31 Dec 2020 10-K 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.